benzodiazepine
The brain has its own brake pedal, a calming chemical signal called GABA that tells nerve cells to fire less. A benzodiazepine does not press the brake itself, but it makes the brake more responsive, so when GABA arrives it works harder. The result is sedation, reduced anxiety, muscle relaxation, and protection against seizures.
Chemically the class is named for its core: a benzene ring fused to a seven-membered diazepine ring bearing two nitrogen atoms. This scaffold, usually carrying an extra aromatic ring and various substituents, is the pharmacophore that fits a special pocket on the GABA-A receptor, a chloride ion channel.
Crucially, benzodiazepines bind an allosteric site distinct from where GABA itself binds. They are positive allosteric modulators: alone they do little, but they increase the channel's response to GABA, letting more chloride flow and quieting the neuron. Examples include diazepam, lorazepam, and midazolam, differing mainly in how fast and how long they act.
An honest caveat: with regular use the brain adapts, so tolerance and physical dependence can develop, and stopping suddenly can trigger withdrawal. They are therefore generally intended for short-term or carefully managed use.
Diazepam binds the benzodiazepine pocket of the GABA-A receptor and, as a positive allosteric modulator, amplifies GABA's calming effect rather than opening the channel on its own.
A positive allosteric modulator acting at a site separate from the natural ligand.
The 'benzodiazepine ring' is also a celebrated privileged structure: the same scaffold, decorated differently, can hit several unrelated receptor families.